Cargando…

Focal Boost in Prostate Cancer Radiotherapy: A Review of Planning Studies and Clinical Trials

SIMPLE SUMMARY: By delivering escalated doses to biologically defined sub-volumes within a target, focal boost radiotherapy is expected to enable an elevated tumor control without an increase in toxicity in prostate cancer. Evidence for the efficacy and variability of this approach has been summariz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yutong, Haworth, Annette, Rowshanfarzad, Pejman, Ebert, Martin A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572027/ https://www.ncbi.nlm.nih.gov/pubmed/37835581 http://dx.doi.org/10.3390/cancers15194888

Ejemplares similares

Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview
por: Her, Emily Jungmin, et al.
Publicado: (2020)

Commissioning and performance characteristics of a pre-clinical image-guided radiotherapy system
por: Feddersen, Theresa V., et al.
Publicado: (2019)

Correction factors for commissioning and patient specific quality assurance of stereotactic fields in a Monte Carlo based treatment planning system: TPS correction factors
por: Goodall, Simon K., et al.
Publicado: (2023)

Evaluation of a mobile C‐arm cone‐beam CT in interstitial high‐dose‐rate prostate brachytherapy treatment planning
por: Djukelic, Mario, et al.
Publicado: (2019)

Dosimetric evaluation of an intraoperative radiotherapy system: a measurement-based and Monte-Carlo modelling investigation
por: Chin, Marsha, et al.
Publicado: (2023)

Focal therapy for prostate cancer: the technical challenges
por: Haworth, Annette, et al.
Publicado: (2017)

Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial
por: Yahya, Noorazrul, et al.
Publicado: (2014)

Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies
por: Kendrick, Jake, et al.
Publicado: (2021)

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
por: Nicholls, Luke, et al.
Publicado: (2020)

A biological modelling based comparison of radiotherapy plan robustness using photons vs protons for focal prostate boosting
por: Pedersen, Jesper, et al.
Publicado: (2018)

Matched linac stereotactic radiotherapy: An assessment of delivery similarity and distributive patient‐specific quality assurance feasibility
por: Goodall, Simon K, et al.
Publicado: (2022)

Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer
por: Yeo, Inhwan, et al.
Publicado: (2015)

Use of focal radiotherapy boost for prostate cancer: radiation oncologists’ perspectives and perceived barriers to implementation
por: Zhong, Allison Y., et al.
Publicado: (2023)

Automated treatment planning of prostate stereotactic body radiotherapy with focal boosting on a fast‐rotating O‐ring linac: Plan quality comparison with C‐arm linacs
por: De Roover, Robin, et al.
Publicado: (2021)

Radiotherapy planning of spine and pelvis using single-energy metal artifact reduction corrected computed tomography sets
por: Ignatius, Daliya, et al.
Publicado: (2023)

Risk of cardiac implantable device malfunction in cancer patients receiving proton therapy: an overview
por: Mirzaei, Milad, et al.
Publicado: (2023)

Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [(68)Ga]Ga-PSMA-11 PET/CT images
por: Kendrick, Jake, et al.
Publicado: (2022)

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
por: Belliveau, C., et al.
Publicado: (2022)

Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
por: Tree, Alison, et al.
Publicado: (2013)

A statistical, voxelised model of prostate cancer for biologically optimised radiotherapy
por: Finnegan, Robert N, et al.
Publicado: (2022)

Quantitative [(68)Ga]Ga-PSMA-11 PET biomarkers for the analysis of lesion-level progression in biochemically recurrent prostate cancer: a multicentre study
por: Kendrick, Jake, et al.
Publicado: (2023)

Deep learning methods for enhancing cone‐beam CT image quality toward adaptive radiation therapy: A systematic review
por: Rusanov, Branimir, et al.
Publicado: (2022)

Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [(68)Ga]Ga-PSMA-11 PET images
por: Kendrick, Jake, et al.
Publicado: (2023)

Investigation of the mechanical performance of Siemens linacs components during arc: gantry, MLC, and electronic portal imaging device
por: Rowshanfarzad, Pejman, et al.
Publicado: (2015)

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results
por: Aluwini, Shafak, et al.
Publicado: (2013)

An EPID-based method for comprehensive verification of gantry, EPID and the MLC carriage positional accuracy in Varian linacs during arc treatments
por: Rowshanfarzad, Pejman, et al.
Publicado: (2014)

Comparison of conventional versus customised Eurosil-4 Pink bolus for radiotherapy of the chest wall
por: Gill, Ashlesha, et al.
Publicado: (2022)

Prospective inter- and intra-tracer repeatability analysis of radiomics features in [(68)Ga]Ga-PSMA-11 and [(18)F]F-PSMA-1007 PET scans in metastatic prostate cancer
por: Kendrick, Jake, et al.
Publicado: (2023)

Visualising the urethra for prostate radiotherapy planning
por: Richardson, Matthew, et al.
Publicado: (2021)

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020)

Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate
por: Bansal, A., et al.
Publicado: (2012)

A prospective comparison of adaptive and fixed boost plans in radiotherapy for glioblastoma
por: Matsuyama, Tomohiko, et al.
Publicado: (2022)

An Investigation of Multileaf Collimator Performance Dependence on Gantry Angle Using Machine Log Files
por: Hughes, Jeremy L., et al.
Publicado: (2021)

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer
por: Chu, William, et al.
Publicado: (2015)

Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost
por: Skrobala, Agnieszka, et al.
Publicado: (2023)

Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review
por: Duijzentkunst, D. A. Smit, et al.
Publicado: (2016)

Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer
por: Mak, Daisy, et al.
Publicado: (2012)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
por: Kim, Hun Jung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7gera178nl276kgr51ugc7900k